Relation between Guillain-Barré syndrome and Covid-19 : Case-Series
©2023 JOURNAL of MEDICINE and LIFE..
Approximately two-thirds of the Guillain-Barré syndrome (GBS) cases are preceded by upper respiratory tract infection or enteritis. There has been previous documentation of a clear association between Covid-19 and GBS. Covid-19 can affect the nervous tissue either through direct damage or through triggering a host immune response with subsequent development of autoimmune diseases such as GBS. Covid-19 can affect the host`s immune system through the activation and interaction of the T-and B-lymphocytes with subsequent production of antibodies that cross-react with the gangliosides. Depending on the nature of the neuronal autoimmune destruction, the affected individual may have either a demyelinating or axonal subtype of GBS. These subtypes differ not only in symptoms but also in the likelihood of recovery. This report presents two cases of GBS that developed after the respiratory symptoms of Covid-19. Their neurological features indicated demyelination, axonal damage, irritation of spinal nerve roots, and impaired sensory and motor transmission with additional facial nerve palsy in the second-studied case. This case report highlights the relationship between GBS and Covid-19 infection.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
---|---|
Enthalten in: |
Journal of medicine and life - 16(2023), 9 vom: 14. Sept., Seite 1433-1435 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Jumagaliyeva, Merey Bakytzhanovna [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 19.12.2023 Date Revised 19.12.2023 published: Print Citation Status MEDLINE |
---|
doi: |
10.25122/jml-2023-0275 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM365984221 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM365984221 | ||
003 | DE-627 | ||
005 | 20231227134549.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231227s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.25122/jml-2023-0275 |2 doi | |
028 | 5 | 2 | |a pubmed24n1232.xml |
035 | |a (DE-627)NLM365984221 | ||
035 | |a (NLM)38107719 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Jumagaliyeva, Merey Bakytzhanovna |e verfasserin |4 aut | |
245 | 1 | 0 | |a Relation between Guillain-Barré syndrome and Covid-19 |b Case-Series |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 19.12.2023 | ||
500 | |a Date Revised 19.12.2023 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a ©2023 JOURNAL of MEDICINE and LIFE. | ||
520 | |a Approximately two-thirds of the Guillain-Barré syndrome (GBS) cases are preceded by upper respiratory tract infection or enteritis. There has been previous documentation of a clear association between Covid-19 and GBS. Covid-19 can affect the nervous tissue either through direct damage or through triggering a host immune response with subsequent development of autoimmune diseases such as GBS. Covid-19 can affect the host`s immune system through the activation and interaction of the T-and B-lymphocytes with subsequent production of antibodies that cross-react with the gangliosides. Depending on the nature of the neuronal autoimmune destruction, the affected individual may have either a demyelinating or axonal subtype of GBS. These subtypes differ not only in symptoms but also in the likelihood of recovery. This report presents two cases of GBS that developed after the respiratory symptoms of Covid-19. Their neurological features indicated demyelination, axonal damage, irritation of spinal nerve roots, and impaired sensory and motor transmission with additional facial nerve palsy in the second-studied case. This case report highlights the relationship between GBS and Covid-19 infection | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a CSF: Cerebro-spinal fluid | |
650 | 4 | |a CT: Computerized tomography | |
650 | 4 | |a Covid-19 | |
650 | 4 | |a Covid-19: Corona-virus disease-19 | |
650 | 4 | |a GBS | |
650 | 4 | |a GBS: Guillain-Barré syndrome | |
650 | 4 | |a Guillain-Barré syndrome | |
650 | 4 | |a ICU: Intensive care unit | |
650 | 4 | |a MFS: Miller-Fisher syndrome | |
650 | 4 | |a MRC: Medical Research Council | |
650 | 4 | |a PCR: Polymerase chain reaction | |
650 | 4 | |a SARS: Severe acute respiratory syndrome | |
650 | 4 | |a TR: Tendon reflexes | |
650 | 4 | |a UTI: Urinary tract infection | |
650 | 4 | |a WKMU: West Kazakhstan Medical University | |
700 | 1 | |a Ayaganov, Dinmukhamed Nurniyazovich |e verfasserin |4 aut | |
700 | 1 | |a Abdelazim, Ibrahim Anwar |e verfasserin |4 aut | |
700 | 1 | |a Saparbayev, Samat Sagatovich |e verfasserin |4 aut | |
700 | 1 | |a Tuychibaeva, Nodira Miratalievna |e verfasserin |4 aut | |
700 | 1 | |a Kurmambayev, Yergen Jumashevich |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of medicine and life |d 2008 |g 16(2023), 9 vom: 14. Sept., Seite 1433-1435 |w (DE-627)NLM19467049X |x 1844-3117 |7 nnns |
773 | 1 | 8 | |g volume:16 |g year:2023 |g number:9 |g day:14 |g month:09 |g pages:1433-1435 |
856 | 4 | 0 | |u http://dx.doi.org/10.25122/jml-2023-0275 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 16 |j 2023 |e 9 |b 14 |c 09 |h 1433-1435 |